Cover Image
Market Research Report

Biosurgery Market - Growth, Trends, and Forecast (2020 - 2025)

Published by Mordor Intelligence LLP Product code 921283
Published Content info 114 Pages
Delivery time: 2-3 business days
Back to Top
Biosurgery Market - Growth, Trends, and Forecast (2020 - 2025)
Published: January 1, 2020 Content info: 114 Pages

Market Overview

The biosurgery market studied was anticipated to grow with a CAGR of 7.4%, during the forecast period. The major factors attributing to the growth of the biosurgery market are increasing geriatric population, rising prevalence of chronic diseases and related surgeries, and a strong focus on R&D leading to the launch of new and advanced products. The global increase in the number of geriatrics population and obese people is likely to lead to numerous health consequences, like greater incidences of ortho and neuro problems. Consequently, the geriatric population and population with obesity are at a higher risk of multiple disorders and diseases. According to the United Nations report in 2017, there were an estimated 962 million people aged 60 or over in the world, comprising 13% of the global population. The population aged 60 or above is growing at a rate of about 3% per year. It was estimated that Europe had the highest percentage of the population aged 60 or over in 2017. Thus, the rise in the geriatric and obese population is acting as a major driver for the growth of the biosurgery market.

Scope of the Report

Biosurgery products are used in various surgeries and repair weakened and damaged tissues and bones. Biosurgery has opened a new paradigm in surgical care, wound and tissue management, and regenerative healing. It has even unlocked new potential in regenerative healing with the right mix of biologics and synthetics.

Key Market Trends

Neurology Segment is Expected to Grow with Good CAGR in the Application Segment

  • Neurology and spine-related surgery applications of biosurgery are the major market segments and their growth is driven by a mainly wide application of bone graft substitute products in different biosurgery processes.
  • Another major application segment of biosurgery is orthopedic surgery. Due to the fact that each year the number of orthopedic cases is increasing primarily due to factors such as the increasing obese and aging population.
  • Even the cardiovascular surgery segment is expected to grow with a positive CAGR in the forecast period, and factors such as the increasing number of cardiac problems in the people across the globe are augmenting the market growth.
  • For instance, according to the data provided by the American Heart Association 2019, Cardiovascular disease (CVD) was listed as the underlying cause of death, which have accounted for approximately 840,678 deaths in the United States in the year 2016, this is approximately 1 of every 3 deaths in the region.

North America Dominates the Market and Expected to do Same in the Forecast Period

North America is expected to dominate the overall market, throughout the forecast period. This is due to the increasing number of surgeries, rising obese patients and increasing geriatric population. In the North America region, the United States holds the largest market share due to factors such as increasing count of geriatrics, along with the growing healthcare industry, which is anticipated to stimulate the demand in this region. Substantial investments by governments to strengthen public healthcare delivery is a key factor augmenting the growth of the market.

Competitive Landscape

The biosurgery market is moderately competitive and consists of several major players. In terms of market share, few of the major players are currently dominating the market. Some of the prominent players are vigorously making acquisitions with the other companies to consolidate their market positions across the globe. Companies that are currently vying for a greater revenue share in the global biosurgery market are Baxter International Inc., Johnson & Johnson, Becton Dickinson and Company (C.R. Bard), B. Braun Melsungen AG, CryoLife, Inc.

Reasons to Purchase this report:

  • The market estimate (ME) sheet in Excel format
  • Report customization as per the client's requirements
  • 3 months of analyst support
Table of Contents
Product Code: 67158

Table of Contents


  • 1.1 Study Deliverables
  • 1.2 Study Assumptions
  • 1.3 Scope of the Study




  • 4.1 Market Overview
  • 4.2 Market Drivers
    • 4.2.1 Increasing Geriatric Population
    • 4.2.2 Rising Prevalence of Chronic Diseases and Related Surgeries
    • 4.2.3 Strong focus on R&D leading to the launch of new and advanced products
  • 4.3 Market Restraints
    • 4.3.1 High price of biosurgery products and rising cost of surgical procedures
  • 4.4 Porter's Five Force Analysis
    • 4.4.1 Threat of New Entrants
    • 4.4.2 Bargaining Power of Buyers/Consumers
    • 4.4.3 Bargaining Power of Suppliers
    • 4.4.4 Threat of Substitute Products
    • 4.4.5 Intensity of Competitive Rivalry


  • 5.1 By Product
    • 5.1.1 Bone-Graft Substitutes
    • 5.1.2 Soft-Tissue Attachments
    • 5.1.3 Hemostatic Agents
    • 5.1.4 Surgical Sealants and Adhesives
    • 5.1.5 Adhesion Barriers
    • 5.1.6 Others
  • 5.2 By Application
    • 5.2.1 Orthopedic Surgery
    • 5.2.2 General Surgery
    • 5.2.3 Neurological Surgery
    • 5.2.4 Cardiovascular Surgery
    • 5.2.5 Gynecological Surgery
    • 5.2.6 Others
  • 5.3 Geography
    • 5.3.1 North America
      • United States
      • Canada
      • Mexico
    • 5.3.2 Europe
      • Germany
      • United Kingdom
      • France
      • Italy
      • Spain
      • Rest of Europe
    • 5.3.3 Asia Pacific
      • China
      • Japan
      • India
      • Australia
      • South Korea
      • Rest of Asia-Pacific
    • 5.3.4 Middle East and Africa
      • GCC
      • South Africa
      • Rest of Middle East and Africa
    • 5.3.5 South America
      • Brazil
      • Argentina
      • Rest of South America


  • 6.1 Company Profiles
    • 6.1.1 Baxter International, Inc.
    • 6.1.2 B.Braun Melsungen AG
    • 6.1.3 Becton, Dickinson and Company (C.R. Bard)
    • 6.1.4 Johnson & Johnson
    • 6.1.5 Medtronic, PLC.
    • 6.1.6 MAQUET Holding B.V. & Co. Kg. (Getinge Group)
    • 6.1.7 Cohera Medical Inc.
    • 6.1.8 Integra Lifesciences Holdings Corporation
    • 6.1.9 Commonwealth Serum Laboratories (CSL)
    • 6.1.10 Hemostasis, LLC
    • 6.1.11 CryoLife, Inc.


Back to Top